Cholangiocarcinoma: State of the Art

Cholangiocarcinoma: State of the Art Publisher Pubmed

Moazzami B¹ ; Majidzadeha K² ; Dooghaiemoghadam A¹ ; Eslami P³ ; Razavikhorasani N¹ ; Iravani S² ; Khoshdel A² ; Shahi F¹ ; Dashti H¹ ; Mehrvar A² ; Nassiri Toosi M¹

Show Affiliations

1. Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
2. Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran
3. Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Journal of Gastrointestinal Cancer Published:2020

Abstract

Background: Cholangiocarcinoma (CCA) is the second most frequent primary liver tumor and defined as the heterogeneous group of tumors derived from cells in the biliary tree. Methods and Results: Based on the anatomical locations (intrahepatic, perihilar, and distal), there are various approaches to the diagnosis and treatment of CCA. Imaging modalities, staging classifications, understandings around natural behavior of CCA, and therapeutic strategies have had remarkable progress in recent years. Conclusions: This article reviews and discusses the epidemiology, clinical presentation, diagnosis, and treatment modalities of CCA; determines the appropriate inclusion and exclusion criteria for liver transplantation (LT); and defines the risk of disease progression for patients in the waiting list of LT. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

1. Multimodality Treatment in Unresectable Cholangiocarcinoma, Journal of Contemporary Brachytherapy (2020)

Experts (# of related papers)

View all Related Experts

Niloofar Ayoobi Yazdi (1)

Fatemeh Jafari (1)

Style	Citing Format
MLA	Moazzami B, et al.. "Cholangiocarcinoma: State of the Art." Journal of Gastrointestinal Cancer, vol. 51, no. 3, 2020, pp. 774-781.
APA	Moazzami B, Majidzadeha K, Dooghaiemoghadam A, Eslami P, Razavikhorasani N, Iravani S, Khoshdel A, Shahi F, Dashti H, Mehrvar A, Nassiri Toosi M (2020). Cholangiocarcinoma: State of the Art. Journal of Gastrointestinal Cancer, 51(3), 774-781.
Chicago	Moazzami B, Majidzadeha K, Dooghaiemoghadam A, Eslami P, Razavikhorasani N, Iravani S, Khoshdel A, et al.. "Cholangiocarcinoma: State of the Art." Journal of Gastrointestinal Cancer 51, no. 3 (2020): 774-781.
Harvard	Moazzami B et al. (2020) 'Cholangiocarcinoma: State of the Art', Journal of Gastrointestinal Cancer, 51(3), pp. 774-781.
Vancouver	Moazzami B, Majidzadeha K, Dooghaiemoghadam A, Eslami P, Razavikhorasani N, Iravani S, et al.. Cholangiocarcinoma: State of the Art. Journal of Gastrointestinal Cancer. 2020;51(3):774-781.
BibTex	@article{ author = {Moazzami B and Majidzadeha K and Dooghaiemoghadam A and Eslami P and Razavikhorasani N and Iravani S and Khoshdel A and Shahi F and Dashti H and Mehrvar A and Nassiri Toosi M}, title = {Cholangiocarcinoma: State of the Art}, journal = {Journal of Gastrointestinal Cancer}, volume = {51}, number = {3}, pages = {774-781}, year = {2020} }
RIS	TY - JOUR AU - Moazzami B AU - Majidzadeha K AU - Dooghaiemoghadam A AU - Eslami P AU - Razavikhorasani N AU - Iravani S AU - Khoshdel A AU - Shahi F AU - Dashti H AU - Mehrvar A AU - Nassiri Toosi M TI - Cholangiocarcinoma: State of the Art JO - Journal of Gastrointestinal Cancer VL - 51 IS - 3 SP - 774 EP - 781 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract